How we check: the CareView Check

Every provider on Peptide CareView gets the same five checks. Four are graded. The fifth, the FDA warning-letter search, is shown on the provider's own page and doesn't change the grade. Each check comes from what the provider publishes for any visitor, plus the public source that settles it: a state pharmacy board or FDA.

The four graded checks

1. Named pharmacy and record

Pass: the provider publicly identifies a US pharmacy, and the dated public-board checks shown in the review support an active license for the named facility. Some records are nonresident licenses in another state; the review identifies that jurisdiction and any unresolved home-state check. Flag: no pharmacy is named, the relevant record cannot be matched, a checked record shows current restrictions that trigger our flag, or orders ship from outside the US.

A named partner is not necessarily the pharmacy assigned to your order. Ask for the legal name, street address, actual compounder and dispensing pharmacy before fulfillment, and confirm authorization where you live. One facility's license does not establish every location under that brand. An active license may also have prior disciplinary orders; read those separately. FDA 503B registration identifies an outsourcing facility and does not replace state licensure, approve its products or verify the pharmacy assigned to you.

Why it matters: knowing the facility lets you look up its exact public record. The check evaluates disclosed identity and dated records, not manufacturing quality, clinical outcomes or a guarantee about your future order.

2. Prescriber reviews you first

Pass: the provider says a licensed clinician (a physician, nurse practitioner or physician assistant) reviews your intake, and any required labs, before a prescription is written or anything ships. Video, phone and written visits all count when the provider says which one it uses. Flag: you can buy through a checkout with no clinician step, or the provider doesn't say who prescribes.

Why it matters: a prescription that comes after a real review is the line between care and a shopping cart.

3. Price shown before signup

Pass: the monthly price a new buyer pays for the provider's main product is on its public pages before you enter any contact details, with the billing term next to it. Flag: the price appears only after the intake questions or after you give your email or phone, or the only public figure is a first-month promo or a prepay rate.

Why it matters: you should be able to compare costs without joining a sales funnel. When a price is hidden, the review explains the gap. An older, introductory or unconfirmed figure is not treated as a current standing price.

4. No research-use-only products

Pass: nothing the provider sells is labeled "research use only" or "not for human consumption", and it doesn't sell compounds that aren't cleared for pharmacy compounding. Flag: any product carries that kind of label, or the provider sells patients a compound such as BPC-157, TB-500 or MOTS-c that isn't cleared for pharmacy compounding.

Why it matters: a research-only label means the product isn't made or sold as a medicine for people. The status of each compound is on its status page, with FDA's documents and dates.

The grade

The grade is the number of the four checks a provider passes:

There are no weights and no bonus points. Two providers that pass the same number of checks get the same grade. A provider that has shut down is removed from the lists and has no grade.

The FDA warning-letter search

FDA's warning-letter index is searched for the provider's brand name, its company name and the name in its web address, and every possible match is opened to see who it was addressed to. A letter counts only when it was sent to this brand or the company behind it, never to a different brand that shares a parent company.

When a letter exists, the provider's own review says so near the top, with the date, what it covers, and a link to the letter on FDA's site. It isn't shown on lists, cards or comparisons, and it doesn't change the grade. A letter is something you should know about before you join. It isn't a verdict on the provider.

Where the facts come from

• The provider's own public pages: home, pricing, product pages, how-it-works, FAQ, terms, refund policy and state list, as any visitor sees them. Never an advertising page or a referral link.
• State boards of pharmacy for the exact dated license and disciplinary record. FDA’s 503B list is a separate registration source, not a substitute license.
• FDA for warning letters and compound status.

If two of a provider's own pages disagree, the review identifies the conflict and asks for written clarification. We do not choose a favorable price or contract term without evidence of which plan it governs. If a provider's own pages leave a check's answer open, that check is a flag, and the review says what is still unanswered. It's read for again, and the flag comes down once the provider's own pages settle it. Our own arithmetic, like a yearly total, is labeled as ours.

When a check is run again

A check is re-run when a provider changes the page it depends on, when a reader or the provider reports a change, and at least every 90 days for every Partner and every provider shown on a list. The date in each review's byline is the month its facts were last read.

What a provider can and can't change

A provider can fix the issue on its own live site and ask for a re-check, or send a correction of fact with a public source. It can't see a check before it's published, and it can't get a flag removed by email, by payment, or with a promise of a future fix. A flag comes down when the fix is live on the provider's own public pages. Partners and non-Partners follow the same rules; How we're funded explains the Partner relationship.

What the check leaves out

The CareView Check looks at how a provider operates. It doesn't rate a treatment or tell you whether one suits you. For that, see the evidence pages and talk to a licensed clinician.